
Pragma Bio Secures $10M to Expand Its Proprietary Technology Platform To Discover Novel Medicines
Pragma Bio, the technology-enabled platform for drug discovery formerly known as VastBiome, announced it has raised an additional $10 million in equity to continue its development of proprietary methods in genomic sequencing, artificial intelligence and […]